PL348107A1 - Therapy for improving cognition - Google Patents

Therapy for improving cognition

Info

Publication number: PL348107A1
Authority: PL; Poland
Prior art keywords: therapy; improving cognition; cognition; improving
Prior art date: 1998-10-16

Application number

PL99348107A

Other languages

English (en)

Inventor

Nijs Paul Leonce Irma De

Wim Louis Julien Parys

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-16

Filing date

1999-10-12

Publication date

2002-05-06

1999-10-12 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2002-05-06 Publication of PL348107A1 publication Critical patent/PL348107A1/xx

Links

230000019771 cognition Effects 0.000 title 1
238000002560 therapeutic procedure Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)

PL99348107A 1998-10-16 1999-10-12 Therapy for improving cognition PL348107A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP98203454		1998-10-16
PCT/EP1999/007804 WO2000023057A2 (en)	1998-10-16	1999-10-12	Atypical antiphsychotic in combination with acetylcholinesterase inhibitor for improving cognition

Publications (1)

Publication Number	Publication Date
PL348107A1 true PL348107A1 (en)	2002-05-06

Family

ID=8234219

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL99348107A PL348107A1 (en)	1998-10-16	1999-10-12	Therapy for improving cognition

Country Status (20)

Country	Link
EP (1)	EP1121131A2 (id)
JP (1)	JP2002527469A (id)
KR (1)	KR20010072878A (id)
CN (1)	CN1367697A (id)
AU (1)	AU6472799A (id)
BG (1)	BG105302A (id)
BR (1)	BR9914419A (id)
CA (1)	CA2345767A1 (id)
EE (1)	EE200100136A (id)
HK (1)	HK1039745A1 (id)
HR (1)	HRP20010262A2 (id)
HU (1)	HUP0103781A3 (id)
ID (1)	ID28441A (id)
IL (1)	IL142588A0 (id)
NO (1)	NO20011403L (id)
PL (1)	PL348107A1 (id)
SK (1)	SK4592001A3 (id)
TR (1)	TR200101082T2 (id)
WO (1)	WO2000023057A2 (id)
ZA (1)	ZA200103081B (id)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0102841D0 (en) *	2001-02-05	2001-03-21	Novartis Ag	Organic compounds
AU2006201188B2 (en) *	2001-02-05	2007-11-15	Novartis Ag	New use of iloperidone
BRPI0213564B8 (pt)	2001-10-30	2021-05-25	Novartis Ag	formulação depósito e micropartícula compreendendo iloperidona e polímero poli(d,l-lactídeo-co-glicolídeo), e processo para preparação da referida micropartícula
GB0216416D0 (en)	2002-07-15	2002-08-21	Novartis Ag	Organic compounds
US20040192754A1 (en) *	2003-03-24	2004-09-30	Shapira Nathan Andrew	Methods for treating idiopathic hyperhidrosis and associated conditions
TW200501962A (en) *	2003-04-01	2005-01-16	Novartis Ag	Use of carbamazepine derivatives for the treatment of agitation in dementia patients
WO2006065233A1 (en) *	2004-12-10	2006-06-22	Abbott Laboratories	Fused bicycloheterocycle substituted quinuclidine derivatives
WO2005065645A2 (en) *	2003-12-31	2005-07-21	Actavis Group Hf	Donepezil formulations
US8278345B2 (en)	2006-11-09	2012-10-02	Probiodrug Ag	Inhibitors of glutaminyl cyclase
ATE554085T1 (de)	2006-11-30	2012-05-15	Probiodrug Ag	Neue inhibitoren von glutaminylcyclase
JP5930573B2 (ja)	2007-03-01	2016-06-15	プロビオドルグエージー	グルタミニルシクラーゼ阻害剤の新規使用
EP2142514B1 (en)	2007-04-18	2014-12-24	Probiodrug AG	Thiourea derivatives as glutaminyl cyclase inhibitors
MX2007008642A (es) *	2007-07-16	2009-02-25	World Trade Imp Export Wtie Ag	Composicion farmaceutica que comprende la combinacion de un agente derivado benzisoxazolico y un agente inhibidor reversible de la enzima colinesterasa, indicada para el control y tratamiento de trastornos psicoticos y demencias.
AU2011215870B2 (en)	2010-02-09	2016-01-28	The Johns Hopkins University	Methods and compositions for improving cognitive function
JP6026284B2 (ja)	2010-03-03	2016-11-16	プロビオドルグエージー	グルタミニルシクラーゼの阻害剤
NZ602312A (en)	2010-03-10	2014-02-28	Probiodrug Ag	Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
WO2011131748A2 (en)	2010-04-21	2011-10-27	Probiodrug Ag	Novel inhibitors
EP2686313B1 (en)	2011-03-16	2016-02-03	Probiodrug AG	Benzimidazole derivatives as inhibitors of glutaminyl cyclase
US20140206667A1 (en)	2012-11-14	2014-07-24	Michela Gallagher	Methods and compositions for treating schizophrenia
WO2014144663A1 (en)	2013-03-15	2014-09-18	The Johns Hopkins University	Methods and compositions for improving cognitive function
JP6433482B2 (ja)	2013-03-15	2018-12-05	エージンバイオ，インコーポレイテッド	認知機能を改善するための方法および組成物
WO2016191288A1 (en)	2015-05-22	2016-12-01	Agenebio, Inc.	Extended release pharmaceutical compositions of levetiracetam
ES2812698T3 (es)	2017-09-29	2021-03-18	Probiodrug Ag	Inhibidores de glutaminil ciclasa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5336675A (en) *	1991-05-14	1994-08-09	Ernir Snorrason	Method of treating mania in humans
WO1992020327A1 (en) *	1991-05-14	1992-11-26	Ernir Snorrason	Treatment of fatigue syndrome with cholinesterase inhibitors
JP4640888B2 (ja) *	1997-08-11	2011-03-02	ザユニヴァーシティーオブサウスフロリダ	神経精神性疾患用ニコチンアンタゴニスト
EP1073432B1 (en) *	1998-04-14	2007-08-15	The General Hospital Corporation	Use of d-serine or d-alanine for treating schizophrenia

1999
- 1999-10-12 WO PCT/EP1999/007804 patent/WO2000023057A2/en not_active Ceased
- 1999-10-12 TR TR2001/01082T patent/TR200101082T2/xx unknown
- 1999-10-12 HU HU0103781A patent/HUP0103781A3/hu unknown
- 1999-10-12 BR BR9914419-0A patent/BR9914419A/pt not_active IP Right Cessation
- 1999-10-12 CN CN99812184A patent/CN1367697A/zh active Pending
- 1999-10-12 HR HR20010262A patent/HRP20010262A2/hr not_active Application Discontinuation
- 1999-10-12 KR KR1020017002286A patent/KR20010072878A/ko not_active Withdrawn
- 1999-10-12 PL PL99348107A patent/PL348107A1/xx unknown
- 1999-10-12 EP EP99952580A patent/EP1121131A2/en not_active Withdrawn
- 1999-10-12 IL IL14258899A patent/IL142588A0/xx unknown
- 1999-10-12 CA CA002345767A patent/CA2345767A1/en not_active Abandoned
- 1999-10-12 AU AU64727/99A patent/AU6472799A/en not_active Abandoned
- 1999-10-12 HK HK02100158.6A patent/HK1039745A1/zh unknown
- 1999-10-12 ID IDW20010828A patent/ID28441A/id unknown
- 1999-10-12 EE EEP200100136A patent/EE200100136A/xx unknown
- 1999-10-12 JP JP2000576832A patent/JP2002527469A/ja not_active Withdrawn
- 1999-10-12 SK SK459-2001A patent/SK4592001A3/sk unknown
2001
- 2001-03-01 BG BG105302A patent/BG105302A/xx unknown
- 2001-03-20 NO NO20011403A patent/NO20011403L/no not_active Application Discontinuation
- 2001-04-12 ZA ZA200103081A patent/ZA200103081B/en unknown

Also Published As

Publication number	Publication date
WO2000023057A3 (en)	2000-07-27
TR200101082T2 (tr)	2001-09-21
HRP20010262A2 (en)	2002-06-30
HUP0103781A2 (hu)	2002-03-28
HK1039745A1 (zh)	2002-05-10
NO20011403D0 (no)	2001-03-20
CN1367697A (zh)	2002-09-04
WO2000023057A2 (en)	2000-04-27
HUP0103781A3 (en)	2003-09-29
AU6472799A (en)	2000-05-08
CA2345767A1 (en)	2000-04-27
BR9914419A (pt)	2001-06-26
NO20011403L (no)	2001-03-20
EP1121131A2 (en)	2001-08-08
SK4592001A3 (en)	2001-12-03
BG105302A (en)	2001-11-30
KR20010072878A (ko)	2001-07-31
IL142588A0 (en)	2002-03-10
ID28441A (id)	2001-05-24
ZA200103081B (en)	2002-07-12
JP2002527469A (ja)	2002-08-27
EE200100136A (et)	2002-06-17

Publication	Publication Date	Title
IL142588A0 (en)	2002-03-10	Therapy for improving cognition
AP2002002661A0 (en)	2002-12-31	Combination therapy for oesteoporosis
GB9816263D0 (en)	1998-09-23	Therapeutic agents
GB9806102D0 (en)	1998-05-20	Therapeutic agents
EP1077704A4 (en)	2002-01-30	COMBINATION THERAPY FOR TREATING DEPRESSION
GB9804885D0 (en)	1998-04-29	Therapeutic combination
GB9808663D0 (en)	1998-06-24	Therapeutic agents
GB9813576D0 (en)	1998-08-19	Therapeutic agents
GB9801234D0 (en)	1998-03-18	Therapeutic agents
GB9813006D0 (en)	1998-08-12	Therapeutic agents
AP9901436A0 (en)	1999-03-31	Therapeutic agents
GB9801210D0 (en)	1998-03-18	Therapeutic agents
GB9816556D0 (en)	1998-09-30	Therapy
HUP0101947A3 (en)	2001-12-28	Combination for the treatment of tumors
GB9801397D0 (en)	1998-03-18	Therapeutic agents
GB9801202D0 (en)	1998-03-18	Therapeutic agents
GB9808665D0 (en)	1998-06-24	Therapeutic compounds
GB9810092D0 (en)	1998-07-08	Therapeutic agents
GB9824897D0 (en)	1999-01-06	Therapeutic compounds
GB9811879D0 (en)	1998-07-29	Therapeutic agents
GB9805716D0 (en)	1998-05-13	Therapeutic agents
GB9815317D0 (en)	1998-09-16	Therapeutic agents
GB9816723D0 (en)	1998-09-30	Therapeutic agents
GB0020261D0 (en)	2000-10-04	Therapeutic treatment
GB9808667D0 (en)	1998-06-24	Therapeutic compounds